Sun Pharmaceutical
SUNPHARMA.NS
#384
Rank
โ‚น4.418 T
Marketcap
โ‚น1,841
Share price
1.23%
Change (1 day)
47.57%
Change (1 year)

P/E ratio for Sun Pharmaceutical (SUNPHARMA.NS)

P/E ratio as of December 2024 (TTM): 50.1

According to Sun Pharmaceutical 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 50.0743. At the end of 2022 the company had a P/E ratio of 57.2.

P/E ratio history for Sun Pharmaceutical from 2012 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202257.281.34%
202131.6-46.35%
202058.8126.56%
201926.0-14.48%
201830.4-54.68%
201767.0216.84%
201621.1-15.97%
201525.2-28.47%
201435.2-21.9%
201345.053.53%
201229.3

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.